Corvus Pharmaceuticals CRVS Balance Sheet (2015-2026)

NASDAQ CRVS
$14.39 -0.26 (-1.77%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Corvus Pharmaceuticals Quarterly Balance Sheet

Periods 46 quarters
Latest Jun 2026

Corvus Pharmaceuticals reported total assets of $239.27M and total liabilities of $13.95M for the quarter ended Jun 2026, up 167.5% year over year. This balance sheet covers 46 quarters of results from Mar 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
72.30M63.46M31.46M28.48M24.59M13.16M9.65M7.66M20.11M12.62M7.46M14.84M4.68M8.74M5.00M14.69M2.87M4.58M40.10M18.91M
Short-term InvestmentsInvestments (Current)
43.22M52.17M196.61M196.32M
Cash & Current Investments
72.30M63.46M31.46M28.48M24.59M13.16M9.65M7.66M20.11M12.62M7.46M14.84M4.68M51.96M5.00M14.69M2.87M56.75M236.71M215.23M
Receivables - NetNet Receivables
0.59M0.01M0.03M0.03M0.04M0.07M0.07M0.08M0.09M0.03M0.04M0.04M0.01M
Receivables - OtherOther Receivables
0.28M0.51M0.37M0.37M0.50M0.59M0.43M0.03M0.03M0.04M0.07M
Receivables
1.18M0.01M0.05M0.05M0.07M0.14M0.07M0.08M0.09M0.03M0.04M0.04M0.01M
Prepaid Assets
2.15M1.35M1.05M1.79M1.15M0.77M0.66M0.89M0.92M0.78M0.70M0.98M1.20M2.37M1.20M1.29M1.22M1.43M3.19M5.73M
Current Assets
78.76M71.31M64.37M58.88M51.27M43.66M35.55M37.91M33.09M27.96M22.85M48.26M42.92M54.41M45.49M75.78M66.94M58.21M239.95M220.97M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
0.54M0.45M0.36M0.53M0.45M0.35M0.33M0.29M0.26M0.24M0.21M0.19M0.17M0.15M0.17M0.25M0.22M0.22M0.28M0.83M
Long-Term Investments
36.33M34.27M33.37M30.18M25.91M21.88M20.23M18.02M17.07M16.12M16.07M15.40M15.19M12.54M12.06M11.79M11.53M10.99M10.50M15.11M
Long-Term Deferred Tax
68.02M76.95M
Other Non-Current Assets
0.28M0.24M0.24M0.24M0.25M0.13M0.13M0.13M0.09M0.09M0.09M0.13M0.25M0.63M0.63M0.63M0.85M0.85M1.72M1.71M
Non-Current Assets
40.57M38.14M36.92M33.66M29.08M1.65M22.65M1.44M1.33M1.43M1.27M1.19M1.34M1.32M1.21M1.11M1.00M0.90M0.80M0.69M
Assets
119.32M109.45M101.29M92.54M80.35M68.24M58.20M58.04M51.94M45.55M40.08M64.56M58.81M68.91M59.44M89.46M80.47M71.12M253.19M239.27M
Liabilities
Current Liabilities
Accounts Payables
2.33M1.56M2.19M2.65M4.23M1.98M1.41M2.10M1.40M1.52M1.61M1.21M1.87M2.58M1.31M3.14M1.97M2.49M4.70M4.05M
Payables
2.33M1.56M2.19M2.65M4.23M1.98M1.41M2.10M1.40M1.52M1.61M1.21M1.87M2.58M1.31M3.14M1.97M2.49M4.70M4.05M
Accumulated Expenses
7.96M7.08M5.99M6.37M8.57M7.55M5.62M4.46M4.56M3.97M4.07M4.30M4.21M3.73M3.87M5.01M5.72M6.49M6.99M9.17M
Other Accumulated Expenses
0.13M0.12M0.20M0.13M0.18M0.16M0.38M0.14M0.26M0.24M0.18M0.23M0.40M0.29M0.30M0.35M0.57M0.24M0.21M0.30M
Current Leases
1.01M1.05M1.09M1.14M1.18M1.23M1.26M1.30M1.34M1.37M1.04M0.70M0.35M0.18M0.32M0.35M0.38M0.40M0.43M0.45M
Current Deferred Revenue
Total Current Liabilities
11.30M9.69M9.27M10.16M13.98M10.75M8.29M7.86M7.30M6.87M6.72M13.34M46.41M35.40M9.28M8.51M8.07M9.38M12.11M13.67M
Non-Current Liabilities
Non-Current Deffered Revenue
Preferred Stock Liabilities
Operating Leases
2.87M2.60M2.30M2.00M1.69M1.37M1.04M0.70M0.35M1.37M1.04M0.70M0.35M0.94M0.83M0.73M0.63M0.53M0.41M0.27M
Other Non-Current Liabilities
7.12M40.00M28.91M3.80M
Total Non-Current Liabilities
0.10M1.02M0.94M0.98M0.90M0.77M0.69M0.65M0.59M0.53M0.62M0.59M0.50M0.41M0.32M0.23M0.14M0.06M
Total Liabilities
14.18M12.29M11.57M12.15M15.67M12.12M9.33M8.56M7.65M6.87M6.72M13.34M46.41M36.34M10.11M9.23M8.71M9.91M12.52M13.95M
Shareholder's Equity
Common Equity
105.15M97.16M89.72M80.39M64.68M56.12M48.87M290.00M290.00M38.68M290.00M290.00M12.41M32.57M49.33M80.23M71.77M61.20M240.68M225.33M
Liabilities and Shareholders Equity
119.32M109.45M101.29M92.54M80.35M68.24M58.20M58.04M51.94M45.55M40.08M64.56M58.81M68.91M59.44M89.46M80.47M71.12M253.19M239.27M
Retained Earnings
-257.14M-266.38M-274.70M-283.04M-297.90M-307.70M-315.60M-322.10M-328.10M-334.72M-340.42M-344.70M-384.90M430.86M-381.82M-389.81M-400.00M474.39M667.78M670.56M
Preferred Shares
10.00M10.00M10.00M10.00M
Treasury Shares